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Abstract
BACKGROUND—Limited information is available about testosterone concentrations 
representative of the general US population, especially children, women, and non-Hispanic 
Asians.
METHODS—We obtained nationally representative data for total testosterone (totalT), measured 
with standardized LC-MS/MS, for the US population age 6 years and older from the 2011–2012 
National Health and Nutrition Examination Survey (NHANES). We analyzed 6746 serum samples 
and calculated the geometric means, distribution percentiles, and covariate-adjusted geometric 
means by age, sex, and race/ethnicity.
RESULTS—The 10th–90th percentiles of totalT values in adults (≥20 years) was 150–698 ng/dL 
(5.20–24.2 nmol/L) in men, 7.1–49.8 ng/dL (0.25–1.73 nmol/L) in women, and 1.0–9.5 ng/dL 
(0.04–0.33 nmol/L) in children (6–10 years old). Differences among race/ethnic groups existed in 
children and men: covariate-adjusted totalT values in non-Hispanic Asians were highest among 
children (58% compared to non-Hispanic black children) and lowest among men (12% compared 
to Mexican-American men). Covariate-adjusted totalT values in men were higher at age 55–60 
years compared to ages 35 and 80 years, a pattern different from that observed in previous 
NHANES cycles.
CONCLUSIONS—TotalT patterns were different among age groups in men compared with 
previous NHANES cycles. Covariate-adjusted totalT values peaked at age 55–60 years in men, 
which appeared to be consistent with the increased use of exogenous testosterone. Differences 
among race/ethnic groups existed and appeared more pronounced in children than adults.
Testosterone is a key hormone for the regulation of sexual differentiation and development. 
It can affect the metabolism of blood lipids and glucose (1, 2). Serum concentrations of 
testosterone are associated with chronic diseases such as cardiovascular disease (3), diabetes 
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mellitus (4), metabolic syndrome (5), and osteoporosis (6) and with mortality (7). 
Testosterone measurements are necessary for the diagnosis of classic hypogonadism in men 
and polycystic ovary syndrome in women (8, 9).
Despite the increasing use of testosterone measurements in patient care and research, only 
limited information is available about testosterone concentrations representative of the 
general US population, especially women, children, and non-Hispanic Asians (NHAs).2 The 
National Health and Nutrition Examination Survey (NHANES) is a population-based survey 
designed to collect nationally representative data in the US household population. The 
sample for this survey represents the US population of all ages and major race/ethnic groups 
for the years 2011 and 2012. Data on testosterone concentrations in serum from male 
participants were reported in earlier NHANES cycles (10). The measurements were limited 
to men, did not provide information on Asian Americans, and were performed with an assay 
reported to be inaccurate, especially at low testosterone concentrations (11, 12). In addition, 
recent studies report an increase in testosterone prescriptions, suggesting changes in 
testosterone concentrations in the US population (13, 14). This situation has created the need 
for new data on testosterone concentrations in the US population with an accurate and 
specific analytical method.
The aim of this study was to obtain nationally representative information about current total 
testosterone (totalT) concentrations in serum from participants age ≥6 years during the 




Samples were obtained from participants of the 2011–2012 NHANES (15). Demographic 
data were collected according to standardized protocols (13). Each participant provided 1 
sample. Serum was collected in non–anticoagulant-containing (red top) vacuum tubes, 
processed by a standard protocol (16), shipped frozen on dry ice, and stored at −70 °C until 
analysis. Samples were analyzed within 4 weeks after collection. NHANES obtained a 
stratified, multistage probability cluster sample designed to represent the US population on 
the basis of age, sex, and race/ethnicity (17). All participants in the survey gave written 
informed consent. The NHANES protocol was reviewed and approved by the National 
Center for Health Statistics Research Ethics Review Board.
TotalT MEASUREMENT
We used 6746 serum samples from individuals ≥6 years old. TotalT was measured with LC-
MS/MS as previously described (18). In brief, testosterone was isolated from 100 μL serum 
by 2 serial liquid–liquid extraction steps and quantified with [13C] stable isotope–labeled 
testosterone as the internal standard. The method had a non-significant bias to established 
2Nonstandard abbreviations: NHA, non-Hispanic Asian; NHANES, National Health and Nutrition Examination Survey; totalT, total 
testosterone; TC, total cholesterol; HDLC, HDL cholesterol; BMI, body mass index; GM, geometric mean; MA, Mexican American; 
NHB, non-Hispanic black; NHW, non-Hispanic white; CGM, covariate-adjusted geometric mean.
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reference methods at National Institute for Standards and Technology and the University of 
Ghent. Imprecision over 2 years was <4.8%, and the limit of detection was 0.3 ng/dL (0.01 
nmol/L).
BIOMARKER MEASUREMENTS
Diabetes status was determined according to glycohemoglobin A1c (Tosoh Automated 
Glycohemoglobin Analyzer HLC-723G8, standardized by the National Glycohemglobin 
Standardization Program) with a maximum imprecision of 1.2% (19). We categorized 
diabetes status (nondiabetes, A1c <5.6%; prediabetes and diabetes, A1c ≥5.6%) according to 
recommendations from the American Diabetes Association (20). Total cholesterol (TC) and 
HDL cholesterol (HDLC) were measured with a Roche Modular P chemistry analyzer 
(Roche Diagnostics) in a laboratory standardized by the CDC Lipids Standardization 
Program, with a maximum imprecision of 3.2% and 1.5% for HDLC and TC, respectively. A 
previously described LC-MS/MS method (21) was used to quantify cotinine, a biomarker for 
tobacco smoke exposure. We categorized individuals into presumed smokers [cotinine ≥10 
ng/mL (56.8 nmol/L)] and nonsmokers [cotinine <10 ng/mL (56.8 nmol/L)] on the basis of 
the classification described by Benowitz (21). We categorized body mass index (BMI) 
according to WHO criteria (BMI <18.5, underweight; 18.5–24.9, healthy weight; 25.0–29.9, 
overweight; ≥30, obese) (22).
STATISTICAL EVALUATION
Geometric means (GMs) and distribution percentiles were calculated for totalT by age 
groups, sex, and self-reported race/ethnicity [Mexican American (MA), non-Hispanic black 
(NHB), non-Hispanic white (NHW), and NHA]. Individuals not included in one of these 
race/ethnicity groups (“other” in Table 1) were included in the total population estimates. 
GM values were calculated for different collection times (morning, afternoon, evening) and 
fasting status (≥8 h, <8 h). GMs and percentiles were calculated with SUDAAN version 
11.0.1 (Research Triangle Institute). We estimated 95% CIs for GMs on the basis of the 
Taylor series linearization method (23) and adapted CIs for percentiles from the methods of 
Korn and Graubard (24) and Woodruff (25). We calculated covariate-adjusted GMs (CGMs) 
for selected demographic groups separately for men (age ≥20 years), women (age ≥20 
years), and children (6 – 10 years) with least-squares multiple regression adjusted for age (6 
– 10, 20 – 29, 30 – 39, 40 – 49, 50 – 59, 60 – 69, ≥70 years), BMI categories, race/ethnicity, 
physical activity (ideal, intermediate, sedentary), and alcohol consumption (nondrinker, 0 
drinks per day; moderate drinker, >0 but <1 drink per day; heavy drinker, ≥1 drink per day). 
Because of differences in the questionnaires, physical activity in adults and children was 
defined as follows: for adults: ideal, ≥20 min per day (mpd) of vigorous activity, ≥30 mpd 
moderate activity, or ≥30 mpd of combined vigorous and moderate activity; intermediate, 
<20 mpd vigorous and <30 mpd moderate but ≥5 mpd combined; sedentary, ≤5 mpd of 
vigorous, moderate, or combined activity; and for children: ideal, TV/computer use <60 mpd 
and physically active ≥60 mpd; intermediate, TV/computer use <60 mpd and physically 
active <60 mpd or TV/computer use ≥60 mpd and physically active ≥60 mpd; sedentary, 
TV/computer use ≥60 mpd and physically active <60 mpd. Alcohol consumption was not 
considered in the model for children. CGM was not calculated for age group 11–19 years 
because of the high heterogeneity in this group and the lack of data on pubertal status. To 
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arrive at the final model, we used backward elimination to remove nonsignificant 
interactions (P > 0.05). Nonsignificant main effects were kept in the model as confounders 
when they changed the β-coefficients for significant main effects or interactions by >10%. 
Once the backward procedure was completed, main effects and interactions were added back 
into the model 1 at a time and kept if they were significant (P < 0.05). Information about 
prescription testosterone use was not collected in this survey and therefore could not be 
included in the models.
Results
We analyzed serum samples from 6746 participants for totalT. Further details about this 
population are listed in Table 1.
Percentile patterns across age groups were different in men (Fig. 1A) and similar in women 
(Fig. 1B). The percentiles in men showed a first peak at age 16–19 years and then appeared 
to decline with increasing age group for the 10th and 25th percentiles, whereas after an 
initial decline, the higher percentiles showed a second peak at age 60–69 years.
The 10th–90th percentiles of totalT values were 150 – 699 ng/dL (5.20 – 24.2 nmol/L) in 
men, 7.1–49.8 ng/dL (0.25–1.73 nmol/L) in women, and 1.0 – 9.5 ng/dL (0.04 – 0.33 
nmol/L) in children (Fig. 2, A and B; Supplemental Table 1, which accompanies the online 
version of this article at http://www.clinchem.org/content/vol61/issue12). The interindividual 
variability of totalT values, as expressed in the ratio of 90th to 10th percentiles, was highest 
in boys age 11–15 years (ratio of 44), followed by boys and girls age 6 – 10 years (6 for 
boys and 7 for girls), and was similar among participants ≥16 years old (3 among men and 4 
among women). Ratios were similar among race/ethnic groups.
In this population, the GM totalT concentrations collected from fasting adults (age ≥20 
years) were not significantly different for samples collected in the morning, afternoon, or 
evening. Samples collected from fasting adults were consistently higher than those from 
non-fasting adults. These differences were significant only in men and only for samples 
collected in the afternoon (P = 0.0183) and evening (P = 0.0001) (see online Supplemental 
Table 2).
MODEL TO ESTIMATE CGM VALUES
To estimate CGM totalT values, the initial models for men and nonpregnant women included 
race/ethnicity, smoking, fasting status, physical activity, alcohol consumption, and diabetes 
status as categorical variables and age, age2, age3, log10(BMI), log10(TC), and log10(HDLC) 
as continuous variables and 2-way interactions. The final model included all of the main 
effects except log10(TC) and alcohol consumption, and in women, physical activity and 
age3. In women, there were interactions between race/ethnicity and diabetes (P = 0.0008) 
and between fasting status and log10(BMI) (P = 0.0222). In men, there was an interaction 
between smoking status and fasting status (P = 0.0192). In children, the initial model 
included sex, race/ethnicity, physical activity, and fasting status as categorical variables; age, 
age2, log10(BMI), log10(TC), and log10(HDLC) were included as continuous variables. The 
final model included all of the main effects except log10(TC), physical activity, and age2 and 
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no interactions (Table 2). The data set for children was too small to calculate CGM values 
for boys and girls separately.
In this survey, the majority (88.8%) of morning serum collections were obtained from 
fasting participants, and the majority (91.7%) of afternoon and evening collections were 
nonfasting. As a result, the effect of collection time was confounded by fasting status, 
preventing inclusion of both fasting status and collection time in our models. We initially 
restricted our analyses to fasting participants and could not detect a significant difference in 
totalT values among collection times. We then evaluated the effect of fasting status 
separately for morning, afternoon, and evening collection and found a statistically significant 
effect of fasting status only for adult men (see online Supplemental Table 2). Therefore, we 
included fasting status in our final model with the understanding that the observed effects 
may not be due entirely to fasting status alone, but could also be related to collection time.
MEN
CGM totalT concentrations in men peaked at ages 20 and 55–60 years. At age 80 years, 
concentrations were 30% lower than at age 20 (Fig. 3A). TotalT concentrations in MA men 
were 13% higher than in NHA men (P = 0.0038) and 10% higher than in NHW men (P = 
0.0051) (see online Supplemental Table 3). The concentrations for men without diabetes 
were higher than for participants with prediabetes or diabetes (15%, P = 0.0034) (see online 
Supplemental Table 3). Smokers also had higher concentrations than nonsmokers, but the 
results were only statistically significant for nonfasting participants (15% when fasting <8 h, 
P < 0.0001; 3.6% when fasting ≥8 h, P = 0.1769). The CGM totalT concentration in men 
with ideal physical activity was 392 ng/dL, significantly greater than that for men with 
intermediate (343 ng/dL, P = 0.0017) or sedentary (355 ng/dL, P =0.0031) physical activity. 
The concentrations for intermediate and sedentary men were not significantly different (P = 
0.5076). BMI was negatively associated with totalT concentrations. Every 10% increase in 
BMI was associated with a 7.5% (95% CI, 5.9%–9.0%) decrease in totalT. HDLC was 
positively associated with totalT. Every 10% increase in HDLC was associated with a 1.7% 
(95% CI, 0.12%–3.3%) increase in totalT.
WOMEN
The CGM totalT concentrations in women were lower with increasing age (48% lower at 
age 80 years compared with age 20) (Fig. 3B). We observed no differences in totalT 
concentrations among race/ethnic groups for women without diabetes (Table 2). TotalT 
values were higher in smokers compared to nonsmokers (P = 0.039) (see online 
Supplemental Table 4) and were positively associated with HDLC. Every 10% increase in 
HDLC was associated with a 2.7% (95% CI, 1.4%–4.0%) increase in totalT. There was a 
positive association with BMI. Among fasting participants, we observed a 4.85% (95% CI, 
4.77%–4.93%) increase in totalT with every 10% increase in BMI, and among nonfasting 
participants, the increase was 2.34% (95% CI, 2.29%–2.40%) with every 10% increase in 
BMI.
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CGM totalT concentrations in children were higher with increasing age (Fig. 3C) and were 
39% higher in girls than boys (P = 0.0001) (see online Supplemental Table 5). The highest 
concentrations were observed in NHA children and the lowest in NHB children (difference 
between groups 58%, P = 0.0071). BMI and HDLC were positively associated with totalT 
concentrations. Every 10% increase in BMI was associated with a 12.1% (95% CI, 8.2%–
16.2%) increase in totalT, and every 10% increase in HDLC was associated with a 7.0% 
(95% CI, 1.0%–12.9%) increase in totalT.
Discussion
Limited information is available about totalT concentrations representative of the general US 
population. Here we report on totalT values in women, children, and NHAs in the NHANES 
population, which is designed to represent the US population on the basis of age, sex, and 
race/ethnicity. We observed differences in totalT values among race/ethnic groups in men 
and children. NHA children had the highest totalT values among children, and NHA men 
had the lowest totalT values among men. No significant differences were detected among 
race/ethnic groups in women without diabetes. Our findings on totalT values in NHB, NHW, 
and MA men are consistent with those reported in an earlier NHANES population (26). The 
reasons for differences among race/ethnic groups are not fully understood and might be 
related to differences in metabolism of testosterone (27, 28). Further studies are needed to 
assess whether these differences are associated with different health outcomes.
We found that CGM totalT values in men were higher at age 55–60 years than ages 35 and 
80 years. This pattern has not been observed in previous NHANES cycles and other study 
populations, which reported a consistent decline in totalT values with increasing age in men 
(10, 29). Over the past few years, an increase in the use of androgen therapy in men age ≥40 
years has been reported (13, 14). Information about androgen use was not available for this 
NHANES cycle, and our data likely included patients on androgen therapy. Higher totalT 
values were observed only in the higher percentiles of unadjusted totalT distributions, which 
most likely included patients on androgen therapy. Thus, the observed pattern could be 
explained in part by the increased use of androgen therapy. Consistent with observations in 
other study groups (30), totalT values declined with increasing age in women. Our initial 
assessments found a positive association with HDLC values in men, women, and children, 
consistent with findings from other studies (1). The increase in HDLC with increase in 
totalT was highest in children and lowest in men. Further investigations are needed to assess 
how these associations correspond with disease risk and health outcomes.
Serum totalT concentrations exhibit a circadian rhythm, with a peak in the morning and a 
nadir in the evening (31, 32). We observed similar patterns in fasting adults, which were 
nonsignificant. The heterogeneity among individuals in this cross-sectional population, as 
indicated in the ratios of 90th to 10th percentile values, might prevent the detection of 
significant differences between collection times. Testosterone values in nonfasting adults 
were consistently lower than in fasting participants independent of the time of sample 
collection. However, the large difference in the number of participants in each subgroup (see 
online Supplemental Table 1) prevents further, more detailed analysis of the effect of fasting 
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and collection time on totalT values. Our findings on fasting status show different 
associations between totalT and BMI in women and totalT and smoking status in men, 
suggesting that fasting status in addition to collection time should be assessed in patients to 
facilitate the interpretation of totalT values.
The unadjusted percentile values for totalT in men were lower than those reported in other 
population studies (27, 29). This can be explained in part by differences in analytical 
methodologies, such as assay calibration, and differences in population characteristics. Other 
studies aimed toward establishing reference ranges and investigating clinical outcomes, 
whereas our study aimed at assessing totalT values in a representative sample of the US 
population. Therefore, we did not apply exclusion or selection criteria as was done in other 
studies.
The association of BMI and diabetes with totalT concentrations was different for men and 
women. The positive association between totalT values and BMI was similar in children 
ages 6–10 years and women. However, although boys showed a positive association, it was 
negative for men. These findings are consistent with previous reports (29, 33–35). CGM 
totalT values were higher in men without diabetes than in those with diabetes, whereas no 
difference was observed in women. Smokers showed higher totalT concentrations than non-
smokers in both men and women. Men with ideal physical activity had higher totalT values 
then those with less activity. All these observations about diabetes, smoking, and physical 
activity are consistent with previous reports (30, 36 –39).
The aim of this study was to describe totalT values in a representative sample of the US 
population with an accurate, standardized analytical method. This information was used to 
detect changes in totalT values in the population and evaluate factors affecting totalT values. 
The study design and the information collected in the 2011–2012 NHANES is insufficient to 
appropriately define clinical decision levels or explain in detail the underlying causes of our 
observations. Because of the cross-sectional design of this study, further longitudinal studies 
are needed to assess the impact of lifestyle, age, and other factors on testosterone 
concentrations in individuals.
In summary, we quantified totalT concentrations in children, men, and women in a 
representative, cross-sectional sample of the noninstitutionalized US population for the years 
2011 and 2012, including NHAs. We observed a peak in CGM totalT values in men at 
approximately age 55 years and identified differences among race/ethnic groups in children 
and men that warrant further detailed investigations to assess whether these differences are 
associated with different health outcomes. These data were generated with an analytical 
method standardized by the CDC Hormone Standardization Program, which facilitates 
comparability of data generated by other assays standardized by this program.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Percentile values for total testosterone in male (A) and female (B) participants by age 
group
Testosterone, 1 ng/dL = 0.0347 nmol/L.
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Fig. 2. Testosterone distribution (10th, 25th, 50th, 75th, and 90th percentile) in men (A), women 
(B), and children ages 6 – 10 years (C)
Testosterone, 1 ng/dL = 0.0347 nmol/L.
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Fig. 3. Model predicted testosterone values as a function of age with 95% confidence limits 
(dashed lines)
(A), Men. (B), Women. (C), Children. Testosterone, 1 ng/dL = 0.0347 nmol/L.
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Table 1
Characteristics of NHANES 2011–2012 participants.a
Variable Female Male Total
n 3327 3419 6746
Median age, years 37 36 36
Ethnicityb
 MA 406 454 860
 NHA 437 450 887
 NHB 917 874 1791
 NHW 1092 1164 2256
 Other 475 477 952
Time of collection
 Morning 1657 1649 3306
 Afternoon 1174 1236 2410
 Evening 496 534 1030
Fasting statusc
 Fasting 1589 1636 3225
 Nonfasting 1738 1783 3521
BMId
 Underweight 76 70 146
 Normal weight 1270 1280 2550
 Overweight 812 1028 1840
 Obese 1124 1002 2126
 Unknown 45 39 84
Diabetes statuse
 Nondiabetic 1959 1872 3831
 Prediabetic or diabetic 987 1086 2073
 Unknown 381 461 842
Median BMI, kg/m2f 28 27.5 27.7
Median direct HDLC, mmol/L 1.40 1.24 1.32
Median TC, mmol/L 4.71 4.53 4.63
Physical activityf,g
 Ideal 617 767 1384
 Intermediate 496 436 932
 Sedentary 1320 1206 2526
Alcohol usef,h
 Nondrinker 812 569 1381
 Moderate drinker 1177 1201 2378
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Variable Female Male Total
 Heavy drinker 134 427 561
a




Fasting, no meal within the last ≥8 h; nonfasting, meal within the past 8 h.
d
Adults ≥20 years of age: underweight, BMI <18.5; normal, 18.5–24.9; overweight, 25–29.9; obese, ≥30.0.
e
Nondiabetic, glycohemoglobin A1c ≤5.6%; prediabetic and diabetic, glycohemoglobin A1c ≥5.6–6.5%.
f
Adults aged ≥20 years.
g
Ideal, ≥20 min per day (mpd) vigorous activity, ≥30 mpd moderate activity, or ≥30 mpd combined vigorous and moderate activity; intermediate, 
<20 mpd vigorous and <30 mpd moderate but ≥5 mpd combined; sedentary, 0 to <5 mpd vigorous, moderate, or combined activity.
h
Nondrinker, 0 drinks per day; moderate drinker, >0 but < 1 drinks per day; heavy drinker, ≥1 drinks per day.













Vesper et al. Page 16
Table 2
P values for the statistically significant terms in the models used to estimate covariate-adjusted totalT values.
Variable Men Nonpregnant women Children
Race/ethnicity 0.0294 NRa 0.0026
Smoking status NR 0.0390 NA
Fasting status NR NR 0.0041
Diabetes 0.0034 NR NA
Alcohol use NS NS NA
Physical activity 0.0005 NS NS
Age 0.0122 <0.0001 <0.0001
Age2 0.0121 0.0002 NS
Age3 0.0092 NS NA
log10(BMI) <0.0001 NR <0.0001
log10(HDLC) 0.0364 0.0003 0.0235
Sex NA NA 0.0001
Smoking status × fasting status 0.0192 NS NS
Race/ethnicity × diabetes NS 0.0008 NS
Fasting status × log10(BMI) NS 0.0222 NS
a
NR, not reported (main effect significance not reported when the effect is involved in an interaction); NA, not applicable (main effect not included 
in model); NS, not significant (effect was not statistically significant at P >0.05).
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Table 3
Estimated CGMs for totalT in adults in NHANES 2011–2012 age ≥20 years and children 6–10 years by race/





 MA 398 (377–419) 18.3 (16.8–20.0) 3.0 (2.7–3.3)
 NHW 361 (349–373) 18.3 (17.4–19.3) 3.6 (3.3–4.0)
 NHB 376 (355–399) 18.2 (17.0–19.5) 2.8 (2.4–3.2)
 NHA 351 (337–366) 18.3 (16.7–19.9) 4.4 (3.2–5.8)
Age, years
 6.0 1.9 (1.5–2.4)
 6.5 2.2 (1.8–2.7)
 7.0 2.5 (2.1–2.9)
 7.5 2.8 (2.5–3.2)
 8.0 3.2 (3.0–3.5)
 8.5 3.7 (3.4–4.0)
 9.0 4.2 (3.9–4.5)
 9.5 4.8 (4.3–5.3)
 10.0 5.5 (4.8–6.2)
 20 393 (356–433) 29.9 (26.8–33.4)
 25 368 (339–399) 26.3 (24.4–28.5)
 30 356 (330–384) 23.5 (22.3–24.8)
 35 354 (332–377) 21.3 (20.5–22.0)
 40 358 (343–373) 19.5 (18.9–20.1)
 45 365 (356–375) 18.1 (17.5–18.7)
 50 373 (359–387) 17.0 (16.4–17.7)
 55 378 (355–403) 16.2 (15.6–16.9)
 60 378 (348–411) 15.7 (14.9–16.4)
 65 369 (336–405) 15.3 (14.5–16.2)
 70 349 (320–382) 15.2 (14.2–16.3)
 75 318 (292–345) 15.3 (13.9–16.7)
 80 275 (246–308) 15.5 (13.8–17.5)
a
Data are mean (95% CI). Testosterone 1 ng/dL = 0.0347 nmol/L.
b
Women without diabetes.
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